Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells

Molecular Therapy

Volumn 16, Issue 8, 2008, Pages 1490-1499

  Benjelloun, Fatine ^a   Garrigue, Alexandrine ^a   Demerens de Chappedelaine, Corinne ^a   Soulas Sprauel, Pauline ^a   Malassis Séris, Michele ^a   Stockholm, Daniel ^b   Hauer, Julia ^a   Blondeau, Johanna ^a   Rivière, Julie ^a   Lim, Annick ^c   Le Lorc'h, Marc ^d   Romana, Serge ^d   Brousse, Nicole ^d   Pâques, Frederique ^e   Galy, Anne ^b   Charneau, Pierre ^c   Fischer, Alain ^a,d   de Villartay, Jean Pierre ^a,d   Cavazzana Calvo, Marina ^a,d  

^a INSERM   (France)

^b GÉNÉTHON   (France)

^c INSTITUT PASTEUR   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Arvid Wallgrens Backe 20   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIS; GENE PRODUCT; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; FOLLOW UP; GENE TRANSFER; HEMATOPOIETIC STEM CELL; IRRADIATION; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; T CELL LYMPHOMA; T LYMPHOCYTE; THYMOMA; TRANSGENE; VIRAL GENE THERAPY; WILD TYPE;

LENTIVIRUS; MUS;

EID: 48349132972     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.118     Document Type: Article

References (33)

1. Fischer, A (20M). Severe combined immunodeficiencies (SCID). Clin Exp Immunol 122: 143-149.
2. Schwarz, K, Gauss, GH, Ludwig, L, Pannicke, U, Li, Z, Lindner, D et al. (1996). RAG mutations in human B cell-negative SCID. Science 274: 97-99.
3. Moshous, D, Callebaut, I, de Chasseval, R, Comeo, B, Cavazzana-Calvo, M, Le Deist F et al. (2001). Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
4. Revy, P, Buck, D, le Deist, F and de Villartay, JP (2005). The repair of DNA damages/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models. Adv Immunol 87: 237-295.
5. Nicolas, N, Finnie, NJ, Cavazzana-Calvo, M, Papadopoulo, D, Le Deist, F, Fischer, A et al. (1996). Lack of detectable defect in DNA double-strand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts. Eur J Immunol 26: 1118-1122.
6. Kobayashi, N, Agematsu, K, Sugita, K, Sako, M, Nonoyama, S, Yachie, A et al. (2003). Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families. Hum Genet 112 348-352.
7. Noordzij, JG, Verkaik, NS, van der Burg, M, van Veelen, LR, de Bruin-Versteeg, S, Wiegant, W et al. (2003). Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Blood 101: 1446-1452.
8. Moshous, D, Pannetier, C, de Chasseval, R, le Deist, F, Cavazzana-Calvo, M, Romana, S et al. (2003). Partial T and B lymphocyte immunodeficiency and predisposition to lymphorna in patients with hypomorphic mutations in Artemis. J Clin Invest 111: 381-387.
9. Antoine, C, Muller, S, Cant, A, Cavazzana-Calvo, M, Veys, P, Vossen, J et al. (2003). Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: Report of the European experience 1968-99. Lancet 361: 553-560.
10. Rooney, S, Sekiguchi, J, Zhu, C, Cheng, HL, Manis, J, Whitlow, S et al. (2002). Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 10 1379-1390.
11. Li, L, Salido, E, Zhou, Y, Bhattacharyya, S, Yannone, SM, Dunn, E et al. (2005). Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation. J Immunol 174: 2420-2428.
12. Rooney, S, Alt, FW, Lombard, D, Whitlow, S, Eckersdorff, M, Fleming, J et al. (2003). Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J Exp Med 197 553-565.
13. Musio, A, Marrella, V, Sobacchi, C, Rucci, F, Fariselli, L, Giliani, S et al. (2005). Damaging-agent sensitivity of Artemis-deficient cell lines. Eur J Immunol 35: 1250-1256.
14. Darroudi, F, Wiegant, W, Meijers, M, Friedl, AA, van der Burg, M, Fomina, J et al. (2007). Role of Artemis in DSB repair and guarding chromosomal stability following exposure to ionizing radiation at different stages of cell cycle. Mutat Res 615: 111-124.
15. Sirven, A, Ravet, E, Chameau, P, Zennou, V, Coulombel, L, Guetard, D et al. (2001). Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther 3: 438-448.
16. Li, Z, Dullmann, J, Schiedlmeier, B, Schmidt M, von Kalle, C, Meyer, J et al. (2002). Murine leukemia induced by retroviral gene marking. Science 296: 497.
17. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
18. Wu, X, Li, Y, Crise, B and Burgess, SM (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
19. Calmels, B, Ferguson, C, Laukkanen, MO, Adler, R, Faulhaber, M, Kim, HJ et al. (2005). Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 106 2530-2533.
20. Cavazzana-Calvo, M and Fischer, A (2007). Gene therapy for severe combined immunodeficiency. are we there yet? J Clin Invest 117 1456-1465.
21. Morre, DJ, Caldwell, S, Mayorga, A, Wu, LY and Morre, DM (1997). NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch Biochem Biophys 342: 224-230.
22. Wang, S, Morre, DM and Morre, DJ (2003). Sera from cancer patients contain two oscillating ECTO-NOX activities with different period lengths. Cancer Lett 190: 135-141.
23. Lagresle-Peyrou, C, Yates, F, Malassis-Seris, M, Hue, C, Morillon, E, Garrigue, A et al. (2006). Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: A balance between efficiency and toxicity. Blood 107: 63-72.
24. Mostoslavsky, G, Fabian, AJ, Rooney, S, Alt, FW and Mulligan, RC (2006). Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci USA 103: 16406-16411.
25. Will, E, Bailey, J, Schuesler, T, Modlich, U, Balcik, B, Burzynski, B et al. (2007). Importance of murine study design for testing toxicity of retroviral vectors in support of phase 1 trials. Mol Ther 15 782-791.
26. Siapati, EK, Bigger, BW, Kashofer, K, Themis, M, Thrasher, AJ and Bonnet, D (2007). Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells. Eur J Haematol 78: 303-313.
27. Rooney, S, Sekiguchi, J, Whitlow, S, Eckersdorff, M, Manis, JP, Lee, C et al. (2004). Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 101: 2410-2415.
28. Lagresle-Peyrou, C, Benjelloun, F, Hue, C, Andre-Schmutz, I, Bonhomme, D, Malassis-Séris, M et al. (2007). Lentiviral gene-corrected CD34+ cells isolated from Artemis-deficient patients differentiate into functional B cells following injection into NOD-SCID mice. Mol Ther 16: 396-403.
29. Zennou, V, Petit, C, Guetard, D, Nerhbass, U, Montagnier, L and Chameau, P (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185.
30. Pannetier, C, Cochet, M, Darche, S, Casrouge, A, Zoller, M and Kourilsky, P (1993). The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90: 4319-4323.
31. Charrier, S, Stockholm, D, Seye, K, Opolon, P, Taveau, M, Gross, DA et al. (2005). A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 12: 597-606.
32. Schmidt, M, Zickler, P, Hoffmann, G, Haas, S, Wissler, M, Muessig, A et al. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100: 2737-2743.
33. Padilla-Nash, HM, Barenboim-Stapleton, L, Difilippantonio, MJ and Ried, T (2006). Spectral karyotyping analysis of human and mouse chromosomes. Nat Protoc 1: 3129-3142.